Letter: Characterizing Atopic Dermatitis Flares During Tralokinumab Therapy: A Real-World Experience

Abstract

Get full access to this article

View all access options for this article.

References

1. Langan

, Thomas

, Williams

. What is meant by a “flare” in atopic dermatitis? A systematic review and proposal. Arch Dermatol. 2006;142(9):1190–1196.

2. Wollenberg

, Barbarot

, Bieber

, European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS). et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682.

3. Drucker

, Thibau

IJC

, Mantell

, et al. Consensus on a patient-centered definition of atopic dermatitis flare. JAMA Dermatol. 2024;160(10):1099–1106.

4. Trave

, Salvi

, Battaglia

, et al. Frequency and clinical features of disease flares in patients with atopic dermatitis treated with dupilumab. J Dermatolog Treat. 2025;36(1):2495831.

5. Girolomoni

, Busà

. Flare management in atopic dermatitis: From definition to treatment. Ther Adv Chronic Dis. 2022;13.